FI965144A - Sterolijohdannaiset käytettäviksi meioosin säätelyyn - Google Patents

Sterolijohdannaiset käytettäviksi meioosin säätelyyn Download PDF

Info

Publication number
FI965144A
FI965144A FI965144A FI965144A FI965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A
Authority
FI
Finland
Prior art keywords
meiosis
regulation
sterol derivatives
derivatives
sterol
Prior art date
Application number
FI965144A
Other languages
English (en)
Swedish (sv)
Other versions
FI117159B (fi
FI965144A0 (fi
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Nordholm
Henning Thoegersen
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI965144A0 publication Critical patent/FI965144A0/fi
Publication of FI965144A publication Critical patent/FI965144A/fi
Application granted granted Critical
Publication of FI117159B publication Critical patent/FI117159B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
FI965144A 1994-06-23 1996-12-20 Sterolijohdosten käyttö meioosin säätelyyn FI117159B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK75394 1994-06-23
DK24195 1995-03-09
DK24195 1995-03-09
DK9500265 1995-06-23
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (3)

Publication Number Publication Date
FI965144A0 FI965144A0 (fi) 1996-12-20
FI965144A true FI965144A (fi) 1997-02-20
FI117159B FI117159B (fi) 2006-07-14

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965144A FI117159B (fi) 1994-06-23 1996-12-20 Sterolijohdosten käyttö meioosin säätelyyn

Country Status (26)

Country Link
US (1) US5716777A (fi)
EP (1) EP0767798B1 (fi)
JP (1) JP3987105B2 (fi)
KR (1) KR100408369B1 (fi)
CN (1) CN1068333C (fi)
AT (1) ATE248852T1 (fi)
AU (1) AU694240B2 (fi)
BG (1) BG101067A (fi)
BR (1) BR9508074A (fi)
CA (1) CA2192941C (fi)
CZ (1) CZ289407B6 (fi)
DE (1) DE69531682T2 (fi)
DK (1) DK0767798T3 (fi)
ES (1) ES2204955T3 (fi)
FI (1) FI117159B (fi)
HU (1) HUT76343A (fi)
IL (1) IL114294A (fi)
IS (1) IS4404A (fi)
MX (1) MX9700174A (fi)
NO (1) NO314534B1 (fi)
PL (1) PL186688B1 (fi)
RU (1) RU2194510C2 (fi)
SI (1) SI9520077A (fi)
SK (1) SK165596A3 (fi)
UA (1) UA51622C2 (fi)
WO (1) WO1996000235A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU717180B2 (en) * 1995-03-06 2000-03-16 Novo Nordisk A/S Stimulation of meiosis
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
RU2182909C2 (ru) * 1995-06-23 2002-05-27 Ново Нордиск А/С Стероиды, способ регулирования мейоза
JP2001506656A (ja) 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数***調節化合物
KR20010012643A (ko) * 1997-05-16 2001-02-26 에프.지.엠. 헤르만스 20-아랄킬-5α-프레그난 유도체
ATE215555T1 (de) * 1997-06-04 2002-04-15 Akzo Nobel Nv 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose
ES2181321T3 (es) 1997-12-18 2003-02-16 Akzo Nobel Nv Derivados 17beta-aril(arilmetil)oxi(tio)alquilandrostano.
KR20010043558A (ko) * 1998-05-13 2001-05-25 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열 조절 화합물
ATE256144T1 (de) * 1998-05-13 2003-12-15 Novo Nordisk As Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
JP2002516272A (ja) * 1998-05-26 2002-06-04 シエーリング アクチエンゲゼルシヤフト ｃＡＭＰを増大させる化合物を単独でまたは減数***を刺激する少なくとも１つの化合物との組合せ物での不妊治療
HUP0102704A3 (en) * 1998-06-19 2002-09-30 Novo Nordisk As Meiosis regulating steroid compounds and use thereof
US6528501B1 (en) * 1998-12-11 2003-03-04 Akzo Nobel N.V. 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
WO2000036132A1 (en) * 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
CA2359687A1 (en) * 1999-02-10 2000-08-17 Schering Aktiengesellschaft Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
AU2794000A (en) * 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
KR20010093280A (ko) 1999-02-24 2001-10-27 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 불임증 치료
KR20020013505A (ko) * 1999-02-26 2002-02-20 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 감수분열활성 스테롤에 의한 착상율의 증가
AU3285000A (en) * 1999-03-09 2000-09-28 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
KR100757909B1 (ko) * 1999-09-16 2007-09-11 노보 노르디스크 에이/에스 Ｉｖｆ를 위한 조성물
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
WO2001062258A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate using ff-mas
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
MXPA02011271A (es) * 2000-05-18 2003-04-25 Schering Ag Fertilizacion de oocitos envejecidos.
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
US9376462B2 (en) 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
CA2192941C (en) 2009-04-14
IS4404A (is) 1996-12-23
FI117159B (fi) 2006-07-14
HU9603584D0 (en) 1997-02-28
FI965144A0 (fi) 1996-12-20
JP3987105B2 (ja) 2007-10-03
UA51622C2 (uk) 2002-12-16
IL114294A (en) 2002-09-12
NO965516L (no) 1997-02-21
CN1151164A (zh) 1997-06-04
PL317830A1 (en) 1997-04-28
SI9520077A (sl) 1998-06-30
NO965516D0 (no) 1996-12-20
ATE248852T1 (de) 2003-09-15
DK0767798T3 (da) 2003-12-22
CA2192941A1 (en) 1996-01-04
BG101067A (en) 1997-08-29
AU694240B2 (en) 1998-07-16
WO1996000235A1 (en) 1996-01-04
AU2734395A (en) 1996-01-19
BR9508074A (pt) 1997-08-12
HUT76343A (en) 1997-08-28
US5716777A (en) 1998-02-10
SK165596A3 (en) 1997-08-06
EP0767798B1 (en) 2003-09-03
NO314534B1 (no) 2003-04-07
CZ289407B6 (cs) 2002-01-16
JPH10502060A (ja) 1998-02-24
DE69531682D1 (de) 2003-10-09
EP0767798A1 (en) 1997-04-16
PL186688B1 (pl) 2004-02-27
KR100408369B1 (ko) 2004-04-28
RU2194510C2 (ru) 2002-12-20
CN1068333C (zh) 2001-07-11
IL114294A0 (en) 1995-10-31
CZ372596A3 (en) 1997-07-16
DE69531682T2 (de) 2004-07-15
ES2204955T3 (es) 2004-05-01
MX9700174A (es) 1997-04-30

Similar Documents

Publication Publication Date Title
FI965144A (fi) Sterolijohdannaiset käytettäviksi meioosin säätelyyn
BG104247A (en) Resorcinol derivatives
FI972387A (fi) Iholle levitettäviä parasitisidikoostumuksia
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
SE9504661D0 (sv) New compounds
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
DE69530403T2 (de) Analogen des keratinozytenwachstumfaktors
NO306753B1 (no) Reguleringsanordning for stol
DE69712900T2 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
ATE203519T1 (de) Chinolinderivate als antimalariamittel
NO965444D0 (no) Triterpen-derivat samt medikamentell sammensetning omfattende dette
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
SE9801494D0 (sv) Novel use
PL323235A1 (en) Derivatives of piperazine as neurokinin antagonists
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
SE9504662D0 (sv) New compounds
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
DE69614552T2 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117159

Country of ref document: FI